Nunzia Pharmaceutical Company – OTC:NUNZ

$0.06

+0.05

+1900%

Market open

Closed in about 2 hours

Market Cap	24.98M
Enterprise value	21.87M

P/E	-0.17
EV/Sales	N/A
EV/EBITDA	-0.22
Price/Sales	N/A
Price/Book	-113.53
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Nunzia Pharmaceutical Company (OTC:NUNZ): Profit margin
Dec 2022	0	0
Mar 2023	0	0
Jun 2023	0	0
Sep 2023	0	0

Nunzia Pharmaceutical Company (OTC:NUNZ): Debt to assets
Sep 2022	35373	226.69K	640.87%
Mar 2023	0	0
Jun 2023	0	0
Sep 2023	0	0

Nunzia Pharmaceutical Company (OTC:NUNZ): Cash Flow
Dec 2022	0	0	0
Mar 2023	0	0	0
Jun 2023	0	0	0
Sep 2023	0	0	0

Nunzia Pharmaceutical Company
Insider Trading

Nunzia Pharmaceutical Company (OTC:NUNZ): Insider trades (number of shares)
Period	Buy	Sel
Dec 2005	69396	0
Jan 2006	0	5386667
Apr 2006	110000	0
May 2006	58913	0
Jun 2006	10000	0
Oct 2006	125000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	30 Oct 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	25,000	$0.02	$500
Purchase	18 Oct 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	100,000	$0.02	$1,900
Purchase	14 Jun 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	10,000	$0.02	$180
Purchase	3 May 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	3,913	$0.04	$157
Purchase	2 May 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	55,000	$0.42	$23,265
Purchase	28 Apr 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	110,000	$0.04	$4,620
Sale	30 Jan 2006	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	5,386,667	N/A	N/A
Purchase	29 Dec 2005	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	34,698	$0.04	$1,319
Purchase	29 Dec 2005	HENRY G DAVID director, 10 percent owner director, 10 percent owner	Common Stock	34,698	$0.04	$1,319
Purchase	8 Aug 2005	KRON ROGER ALAN director, officer: Chief Operating Officer director, officer: Chief Operat..	Common Stock	245,466	$0.06	$14,973

NUNZ insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Nunzia Pharmaceutical Company stock today?

One share of Nunzia Pharmaceutical Company stock can currently be purchased for approximately $0.06.
When is Nunzia Pharmaceutical Company's next earnings date?

Unfortunately, Nunzia Pharmaceutical Company's (NUNZ) next earnings date is currently unknown.
Does Nunzia Pharmaceutical Company pay dividends?

No, Nunzia Pharmaceutical Company does not pay dividends.
How much money does Nunzia Pharmaceutical Company make?

Nunzia Pharmaceutical Company has a market capitalization of 24.98M.
What is Nunzia Pharmaceutical Company's stock symbol?

Nunzia Pharmaceutical Company is traded on the OTC under the ticker symbol "NUNZ".
What is Nunzia Pharmaceutical Company's primary industry?

Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
How do i buy shares of Nunzia Pharmaceutical Company?

Shares of Nunzia Pharmaceutical Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Nunzia Pharmaceutical Company went public?

Nunzia Pharmaceutical Company is publicly traded company for more then 16 years since IPO on 24 Jul 2009.
What is Nunzia Pharmaceutical Company's official website?

The official website for Nunzia Pharmaceutical Company is nunziapharma.com.
Where are Nunzia Pharmaceutical Company's headquarters?

Nunzia Pharmaceutical Company is headquartered at 1627 West 14th Street, Long Beach, CA.
How can i contact Nunzia Pharmaceutical Company?

Nunzia Pharmaceutical Company's mailing address is 1627 West 14th Street, Long Beach, CA and company can be reached via phone at +7 146099117.

Nunzia Pharmaceutical Company

nunziapharma.com

Exchange:

OTC

Full time employees:

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

+7 146099117

1627 West 14th Street
Long Beach, CA 90813

CIK: 0000886093
ISIN: US67097W1027
CUSIP: 67097W102